Quell-FM Transcutaneous Electrical Nerve Stimulator
De Novo DEN210046
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA De NovoDENG | NumberDEN210046 | Date18 May 2022 | StatusActive |
Official records
- FDA De Novo database DEN210046
From the FDA record
- Received by the FDA
- 5 Oct 2021
- FDA decision
- 18 May 2022
- FDA review time
- 225 days from receipt to decision
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Full name
- Quell-FM
- De Novo Number
- FDA product code
- QSQ
- Device class
- Class II
- Regulation
- 21 CFR Part 882.5888
- Advisory committee
- Neurology
- FDA decision
- DENG De Novo granted
Overview
AI-generated summary, 20 Sep 2026
The Quell-FM is a transcutaneous electrical nerve stimulation (TENS) device classified as a Class 2 Neurology device (product code QSQ). It is designed to provide electrical stimulation to help reduce fibromyalgia symptoms in adults with high pain sensitivity, leveraging transcutaneous nerve modulation to alleviate discomfort. The device operates on the principle of delivering low-level electrical impulses through the skin to modulate pain perception. Its regulatory designation aligns with the FDA’s classification for neuromodulation devices intended for chronic pain management.
The Quell-FM is intended for use during sleep and is supplied with compatible NeuroMetrix electrodes. It is cleared under FDA 510(k) (DEN210046) via the Direct pathway, adhering to regulatory standards for Class 2 devices. No explicit sterility or single-use/reusable designation is provided, though its intended use suggests a reusable design with proper electrode maintenance. The device is not labeled for MRI compatibility or other imaging environments. Storage and handling follow standard electrical medical device protocols as outlined in its user manual.
Devices cleared under DEN210046
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Quell 1.0 QE-BK-AGN | QE-BK-AGN | 00851221006766 | On the market | |
| Quell 2.0 QE-NBK-LBL | QE-NBK-LBL | 00851221006742 | On the market | |
| Quell 2.0 QE-NBK-SBL | QE-NBK-SBL | 00851221006735 | On the market | |
| Quell Charger Adapter QE-CH1 | QE-CH1 | 00851221006797 | On the market | |
| Quell Charger Cable QE-CH2 | QE-CH2 | 00851221006780 | On the market | |
| QUELL FIBROMYALGIA QE-FMG | QE-FMG | 00851221006643 | On the market | |
| QUELL FIBROMYALGIA QE-FMG-4 | QE-FMG-4 | 00851221006384 | On the market | |
| Quell Fibromyalgia QE-FMG-RPL | QE-FMG-RPL | 00851221006810 | On the market | |
| QUELL FIBROMYALGIA QE-FMP | QE-FMP | 00851221006650 | On the market | |
| Quell Fibromyalgia QE-NBK-RBL | QE-NBK-RBL | 00851221006513 | On the market | |
| Quell QE-STX | QE-STX | 00851221006704 | On the market |